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Ab s t r Ac t
The adverse effect of Melphalan (MEP), an anti-cancer compound in the male reproductive system, was investigated.  In this study, 1, 3, or 
5 mg/kg/bwt intraperitoneal doses of MEP were administered daily for 28 days. Half of the mice were sacrificed after 24 hours of the last treatment, 
and the other half were sacrificed 28 days after withdrawal of treatment. Glutathione peroxidase (GPX), glutathione reductase (GR), catalase 
(CAT), superoxide dismutase (SOD), reactive oxygen species (ROS) and lipid peroxidation (LPO) levels of testicular tissue were evaluated. The 
induction of apoptosis was assessed by investigating the level of CASP-3 and CASP-9 activities in spermatogenic cells. CASP- 9, Bax and BCL-2 
expression were checked by real-time PCR and western blotting. Testis weight in MEP-treated mice was significantly decreased. There was a 
significant decrease in sperm parameters, GSH GPx, CAT, and SOD levels, with a concomitant increase in ROS and MDA levels confirming the 
generation of oxidative stress. MEP-treatment leads to the increased expression of CASP-9, BAX, with decreased BCL-2 protein levels in a dose-
dependent manner. No significant recovery after 28 days of withdrawal of the treatment was observed. The results indicate that MEP- treatment 
leads to testicular damage due to the formation of oxidative stress and induction of caspase-dependent apoptosis.
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In t r o d u c t I o n
Melphalan (MEP), a chemotherapy drug belonging to the class of 
nitrogen mustard alkylating agents, exerts its anti-cancer effect by a 
process called alkylation, which damages the deoxyribonucleic acid 
(DNA) of cells, preventing them from dividing and ultimately leads 
to cell death. Since cancer cells, in general, divide faster and with less 
error-correcting than healthy cells, cancer cells are more sensitive 
to this damage. In this way, melphalan slows or stops the growth of 
cancer cells in the body. Melphalan is used in the cure of multiple 
myeloma, ovarian cancer and occasionally malignant melanoma. 
The most frequent dose-limiting toxicity is dose-related, cumulative 
myelosuppression.[1] Irradiation and chemotherapy induce the 
p53 pathway, which is one of the common apoptosis-mediated 
pathways by DNA damage.[2] The series of interactions that occur 
between DNA and Reactive Oxygen Species (ROS) generates 
oxidative stress, which leads to DNA damage.[3] An important 
primary DNA damaging agents are ROS,[4] and an early marker 
of apoptosis is DNA damage.[2,4] Apoptotic events and ROS have 
been reported to have the capacity to increase the fragmentation 
of DNA.[4] ROS levels have been reported to be negatively 
associated with the quality of sperm, sperm viability, and male 
fertility.[3,5]
Under normal testicular conditions, there are several anti-
oxidant mechanisms in seminal plasma and inside the spermatozoa 
that can curb ROS activity, but abnormal conditions mediated 
by some chemotherapy drugs can increase ROS generation 
and induce DNA damaged-related apoptosis in spermatozoa.
[4] ROS has the capacity of activating various signal transduction 
pathways, including the Erk-p38 MAPK cascade.[3,6,7] The Erk-p38 
MAPK cascade mediates Senescence[7] and apoptosis.[2] Bcl-2 family 
proteins have been reported to play a pivotal role in the induction 
of caspases activation and in the regulation of apoptosis, but 
their functions are not yet entirely defined.[8,9] As Bcl-2 proteins 
are involved in the control of apoptosis upstream of caspase-3 
activation and any other irreversible cellular damage, they might 
be important in deciding whether a cell will live or die.[9,10]
Moreover, alterations on the expression of Bcl-2 family members 
that is induced by anti-cancer drug treatment can trigger apoptosis 
in tumors.[2] Apoptosis a tightly regulated process of cell death, 
dependent on the expression of cell-intrinsic suicide machinery and 
are regulated by the family of Bcl-2 family.[10,11] The pro-apoptotic 
(Bax) members of the Bcl-2 family can trigger the apoptotic 
pathways, and anti-apoptotic (Bcl-2) can inhibit the apoptotic 
pathways.[2,12] Based on the literature available, there is not enough 
information about the effects of melphalan on ROS production 
and apoptosis gene expression alteration in testis of mammalian. 
Most of recent studies are about histological and cytotoxic effects 
of melphalan on the reproductive tract of a female.[1] The present 
study, therefore, investigated the effect of melphalan on oxidative 
stress biomarkers enzyme activities and ROS generation in testicular 
tissue. The effect on the apoptosis-related gene and protein 
expression (Bcl-2 family) in testes mice were also examined.
MAt e r I A l s An d Me t h o d s
Animal Preparation
Male Swiss albino mice weighing about 20 g were obtained from the 
Laboratory Animal Division of the University of Ibadan. The animals 
were maintained under standard conditions of humidity (50 ± 5%), 
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temperature (25 ± 2oC) and dark and light cycles (12 hours each) 
with free access to food and water. Mice were divided into eight 
groups of ten animals each and treated intraperitoneally. Groups II, 
III, and IV received 1, 3, 5mg/kg melphalan respectively, and group 
one received the vehicle and served as control were sacrificed 24 
hours after the last treatment while groups V, VI, VII and VIII were 
sacrificed 28 days after withdrawal of treatment. 
Testes Weight and Testicular Tissue Sample 
Preparation
Mice were weighed daily prior to the administration of MEP. At 
autopsy, testis was removed, blotted free of blood and adhering 
tissues and weighed. Testis tissue was immediately removed, 
weighed and washed with ice-cold saline solution, blotted free of 
excess moisture, deep-frozen in liquid nitrogen and stored at −20°C 
until preparation of cytosolic fractions. 
Biochemical Analysis
Testis homogenate (10%, w/v) was prepared in chilled 100 Mm Tris-
HCL buffer (pH 7.4) and the homogenate was used to measure GPx, 
GR, GSH, GST, CAT, and SOD activities by using spectrophotometry 
method. Protein content in the samples was estimated, according 
to Lowry et al. All the parameters were expressed per mg protein.
de t e c t I o n o f Ap o p to s I s 
Preparation of Spermatogenic Cells
Testis was removed and homogenized in 15 mL tube containing 10 
mL ice-cold 1X PBS buffer (pH 7.4) and the contents were incubated 
for 40 minutes at 37oC with vigorous shaking. Then, the tubes were 
placed on ice and incubated to allow the spermatogenic cells to 
settle. The supernatant was discarded, and cells were washed twice 
in 10 mL of PBS twice.
Analysis of Apoptosis Using Flow Cytometer
Annexin V-fluorescein isothiocyanate/propidium iodide is a 
sensitive and precise quantification method for detecting very 
early stages by flow cytometer analysis. Briefly, testis tissue was 
homogenized in PBS by centrifugation at 1500 x g for 5 minutes 
each. Cells were washed and re-suspended with phosphate-
buffered saline (PBS). Fluorescein isothiocyanate-conjugated 
annexin V and PI (BD Biosciences Pharminge USA) were added at 
the manufacturer’s recommended concentrations to 0.1mL aliquots 
containing cells. Cells were incubated for 15 minutes at 25oC in the 
dark. Cell suspensions were diluted with 0.4 mL of binding buffer 
and then analyzed by flow cytometry within 1-hour. Flow cytometry 
was performed on Model- FACS Calibur flow cytometer (BD, San 
Jose, CA, USA) using Cell Quest Pro software (BD). 
Effect on CASP-3 and CASP-9 Activities
Spermatogenic cells were used for the detection of CASP- 3 
and 9 activities by using colorimetric assay kits according to the 
manufacturer’s protocol. Briefly, spermatogenic cells were washed 
with 1X PBS buffer 2 times at 500 x g for 5 minutes the pellet was 
dissolved in the extraction buffered and processed for activity 
assay.
RNA Isolation and cDNA Preparation
Total RNA was isolated from mice testis using TRIzol reagent 
(Invitrogen USA). A total of 100 mg of testes tissue from different 
treated groups was homogenized in 1 mL of TRIzol reagent and 
was kept at room temperature for 5 minutes, after which 200 μL 
chloroform was added. This was mixed vigorously for about 15 sec, 
and the homogenates were then kept at room temperature for 10 
minutes followed by centrifugation at 13,500 rpm for 15 minutes 
at 4oC. The upper colorless aqueous phase containing RNA was 
collected. To precipitate RNA, isopropanol was added, mixed, and 
kept at room temperature for 10 minutes. Thereafter, samples were 
spun at 13,500 rpm for 10 minutes at 4oC. RNA precipitate obtained 
was washed by adding 75% ice-cold ethanol and spinning at 7500×g 
for 5 minutes at 4oC. After removing the ethanol, the RNA pellet 
was briefly air-dried and then dissolved in DEPC-treated water. RNA 
concentration and purity were determined at an optical density 
of 260/280 using nanodrop (Quawell UV-VIS spectrophotometer 
Q5000). cDNA was prepared according to supplier protocol 
(Invitrogen, USA). 
Determination of mRNA Level Using Real-time RT-PCR
Real-time PCR analysis was performed according to the supplier’s 
instruction (Roche Diagnostics Germany). The components of 
the reaction were SYBR Green PCR Master Mix, cDNA template, 
forward primer and reversed primers and nuclease-free water. PCR 
reactions were performed in Light Cycler ®480 (Roche Diagnostics 
Ltd Germany). For each primer pair, a melting curve analysis was 
performed according to the manufacturer’s instruction. The 
program, in brief, was an initial incubation of 50oC for 2 minutes, 
and 95oC for 10 minutes was followed by 40 cycles at 95oC for 15 
seconds 60oC for 60 seconds. Experiments were carried out in 
triplicates and Cp values were calculated. β-actin was used as an 
internal control to normalized ratios between the samples. Relative 
changes in mRNA level between control and treated groups were 
calculated by using 2-∆∆CT (Table 1).
Western Blotting 
Proteins were isolated from testis tissue by using a modified 
protocol of Ghribi et al. (2001). Testis tissues were homogenized 
in urea lysis buffer. Cellular debris was spun down at 20,000 x 
g for 30 minutes at 4oC, and supernatants were used as whole 
Table 1: Sequences of primers used for real-time quantitative PCR
Name Sequence Accession number
BCL-2 Sense CTGGGAGATCAAAATCGACCC NM_013863
Antisense GCTGAAGATGCAGTGTCCTTAG
BAX Sense TCCCACATAACTCCCTCGACA NM_026669
Antisense GTGTGTGACCACATGGACATAG  
CASP-9 Sense TCC TAC ATC GAG ACC TTG NM_015733
Antisense AAG TCC CTT TCG CAG AAA CAG
β-Actin Sense AAGAGTCCCTCATACTACAGGTG NM_008905
Antisense CACACTTCAAGGTCCCGAATC
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protein extract. Isolated proteins were quantified using Bradford 
reagent. A 50 µg proteins from each sample was separated on 
15% SDS-PAGE and transferred to nitrocellulose membrane using 
a semi-dry electro-blotting apparatus (GE Health, UK). The transfer 
was examined by Ponceaus stain and washed in distilled water 
until the stain disappeared. The membrane was incubated in 5% 
non–fat dried milk at 4oC overnight. The blocked membrane was 
washed with 0.1% PBST and probed with primary antibodies. After 
primary antibody incubation, further washing was done in 0.05% 
PBST. The membrane was incubated in HRP conjugated secondary 
antibody and rewashed three times. Enhanced chemiluminescent 
detection reagent was used to develop the blots. The expression 
levels of proteins detected by immunoblotting were quantitated 
using the program IMAGE (National Institutes of Health, USA) for 
the integrated density of each band. Quantitative Western blot data 
were calculated from the densitometric analysis of bands with the 
NIH Image J software. The values were normalized to β-actin, which 
served as a loading control.
Statistical Analysis
All statistical comparisons between the groups were made using 
analysis of variance (ANOVA) by Prism statistics software. Results 
were presented as Mean ± SD (n = 5). Values of p < 0.05 were 
considered as statistically significant.
re s u lts
Effects of MEP Treatment on Testis Weights
The weight of testis was significantly reduced following MEP 
treatment for 28 days. No sign of significant recovery was seen 
after 28 days withdrawal of MEP treatment (Table 2).
MEP Induces Oxidative Stress
The activities of glutathione-related enzymes such as GPx, GR, 
and GST in the testis tissue of both the control and experimental 
animals are given in Table 2. The activities of GPx, GR, and GST were 
significantly lowered (p < 0.05). Also, MEP depletion of reduced 
glutathione (GSH) was recorded following MEP treatment. Levels of 
SOD and CAT in the testis of the animal treated with MEP, especially 
at 5 mg/kg were significantly lowered compared to control mice 
(p < 0.05) with a simultaneous increased level of lipid peroxidation. 
These results suggest a generation of oxidative stress (Table 3).
Effect of MEP on CASP-3 and CASP-9 Activities
Activation of CASP-3 and 9 activities was seen after 28 days 
MEP treatment in dose dose-dependent pattern (Figure 1). No 
significant recovery was seen after 28 days of withdrawal of MEP 
treatment. This indicates that MEP mediated a cascaded series of 
molecular events that led to the induction of apoptosis.
MEP Induces Apoptosis in Primary Spermatogenic 
Cells 
MEP treatments result in an increased percentage of Annexin 
V-positive in groups II, III, and IV that received 1, 3, and 5 mg/kg 
respectively in a dose-dependent pattern (Figure 2). The ability 
of MEP to induce apoptosis in the spermatogenic cells after the 
withdrawal of the treatment was also noticeable. Increased necrosis 
of spermatogenic cells exhibiting 35.15, 50.15, and 59.31% following 
MEP treatment at 1 mg/kg, 3 mg/kg, and 5 mg/kg respectively, 
was also seen after the addition of propidium iodide. A significant 
increase following withdrawal after 28 days of MEP treatments 
was also seen (29.32, 40.92, and 48.84%) as compared to the 
controls. 
Table 2: Effects of MEP on Testes weight
Treatment and doses (mg/kg body weight/day Testes/body weight (%)
Group I  (Control) 6.60 ± 0.28
Group II (1mg/kg) 5.33 ± 0.25
Group III (3mg/kg) 4.8 ± 0.29*
Group IV (5mg/kg) 3.93 ± 0.19**
Group V (Control) 6.26 ± 0.28
Group VI (1mg/kg) 5.05 ± 0.21
Group VII (3mg/kg) 4.9 ± 0.10*
Group VIII(5mg/kg) 4.10 ± 0.14**
The data are expressed as mean ± SD (n = 5). *,  **,  and  ***  indicate  significant  difference  as  compared  to  controls  at (p <0.05), (p <0.01), 
and (p <0.001) respectively.
Table 3: Effect of MEP treatment on biochemical enzymes.
Treatment and doses 
(mg/kg)
GPx
(U/mg 
protein)
GR
(nM/min/
mg protein)
GST
(nmol/min/
mg protein)
GSH
µM/
mg protein)
LPO
(nmol/min/
mg protein)
SOD
(U/mg/protein)
CAT
(µmol/min/
mg protein)
Group I (Control) 2.14 ± 0.15 0.12 ± 0.01 1.20 ± 0.14 0.83 ± 0.04* 0.45 ± 0.03 2.02 ± 0.18 24.39 ± 0.89
Group II (1mg/kg) 1.59 ± 0.13 0.09 ± 0.01 1.00 ± 0.12 0.47 ± 0.03** 0.78 ± 0.06** 1.47 ± 0.14 20.08 ± 2.40
Group III (3mg/kg) 1.09 ± 0.13** 0.05 ±0.03** 0.67 ± 0.06 0.25 ± 0.05 0.98 ± 0.03** 0.91 ± 0.09** 18.20 ± 3.10**
Group IV (5mg/kg) 0.78 ± 0.15*** 0.03 ± 0.01* 0.38 ± 0.02*** 0.19 ± 0.01 1.75 ± 0.12** 0.56 ± 0.09** 15.47 ± 1.70***
Group V (Control) 1.80 ± 0.09 0.11 ± 0.01 1.11 ± 0.17 0.76 ± 0.05*** 0.42 ± 0.03 1.80 ± 0.10 27.67 ± 2.92
Group VI (1mg/kg) 1.12 ± 0.09* 0.08 ± 0.01 0.89 ± 0.20 0.58 ± 0.07** 0.82 ± 0.10** 1.58 ± 0.13* 22.85 ± 1.59*
Group VII (3mg/kg) 0.91 ± 0.10** 0.05 ± 0.00** 0.66 ± 0.14 0.51 ± 0.04 1.17 ± 0.14*** 1.29 ± 0.08** 18.86 ± 1.93**
Group VIII(5mg/kg) 0.73 ± 0.10** 0.03 ± 0.00* 0.37 ± 0.03* 0.25 ± 0.02 1.43 ± 0.16*** 1.00 ± 0.07*** 16.61 ±2.42***
The data are expressed as mean ± SD (n = 5). *, **,  and  ***  indicate  significant  difference  as  compared  to  controls  at (p < 0.05), (p < 0.01), 
and (p < 0.001) respectively.
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Effect on BAX, CASP-9, and BCL-2 mRNA expression
MEP treatment at doses 3 and 5 mg/kg results in the marked increase 
in the gene expression level of Bax and CASP-9. The expressions 
of these genes were also detected 28 days after withdrawal of the 
treatment. However, reduced expression of anti-apoptotic gene 
BCL-2 was seen in all the treated groups. Statistical analysis indicates 
that increased levels of both apoptotic genes were significantly 
different from mice in control groups (Figure 3).
Figure 3: Bar chat represents the fold change of CASP-9, BAX, and BCL-2 genes in testes of mice treated with MEP for 28days and following 28 
days withdrawal of the treatment. The data are expressed as mean ± SD (n = 5). *,  **,  and  ***  indicate  significant  difference  as  compared  to 
controls  at (p < 0.05), (p < 0.01), and (p < 0.001), respectively.
Figure 2: Shows numbers of apoptotic cells in the sample.  Note: The data are expressed as mean ± SD (n = 5). *,  **,  and  ***  indicate  
significant  difference  as  compared  to  controls  at (p < 0.05), (p < 0.01), and (p < 0.001), respectively.
Figure 4 (a to b): Effect of MEP on CASP-9, BAX, and BCL-2 protein expression. The data are expressed as mean ± SD (n = 5). *,  **,  and  ***  
indicate  significant  difference  as  compared  to  controls  at (p <0.05), (p <0.01), and (p <0.001), respectively.
Figure 1:  Effect of MEP on CASP-3 and CASP-9 activities of spermatogenic cells after 28 days MEP treatment and following 28 days of 
withdrawal of treatment. Note: The data are expressed as mean  ± SD (n = 5). *,  **,  and  ***  indicate  significant  difference  as  compared  to  
controls  at (p < 0.05), (p < 0.01), and (p <0.001), respectively.
(c)(b)(a)
(b)(a)
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Effect of MEP on the Expression of BAX, BCL-2 and 
CASP-9 Proteins
Melphalan lead to 4 fold change increased expression of Bax and 
CASP- 9 proteins. Reduced BCL-2 expression in a dose-dependent 
manner within total hepatic cell was also observed (Figures 4a 
and b). 
dI s c u s s I o n
The present study demonstrated that treatment with melphalan 
resulted in spermatogenic dysfunctions, such as the deterioration of 
seminiferous tubules and the loss of spermatogenic cells. Reactive 
Oxygen Species are produced in a normal range routinely as a result 
of cellular activities and they are regulated by the anti-oxidant, 
anti-oxidant defense system to curb oxidative stress. Melphalan 
significantly meditated decrease in the levels of enzymatic anti-
oxidants, anti-oxidants including GPx, Cat, GR, GSH, GST and SOD, 
and an increased level of lipid peroxidation in sperm and testis 
tissue of treated mice. In this present study, signs of oxidative 
stress were indicated by increased MDA activity in the testis of the 
MEP-treated mice. The drug-treated mice also showed a defective 
anti-oxidant, anti-oxidant response as noticed from diminished 
activity of anti-oxidant, anti-oxidant enzymes such as CAT, SOD, 
GPx and the non-enzymatic anti-oxidant, anti-oxidant GSH. The 
pro-apoptotic Bax and anti-apoptotic Bcl-2 are two extremely 
important regulatory molecules involved in cell death, and the 
ratio of Bax/Bcl-2 is an important factor that decides whether 
apoptosis will occur in cells. The MEP-treated mice had increased 
level of Bax (therefore, increased ratio of Bax/Bcl-2) and decreased 
Bcl-2 expression in their testis tissues causing a significant change 
from the normal equilibrium of Bax/Bcl-2. The significant changes 
of Bcl-2 family gene expression level as the main regulatory markers 
of apoptosis showed melphalan mediated apoptosis in epididymal 
sperm of treated mice. This fact confirms Bcl-2 family gene-induced 
apoptosis in normal tissue following melphalan administration. 
Recent reports showed ROS ability to regulate the phosphorylation 
and ubiquitination of Bcl-2 family of proteins and change of the 
activity of these apoptotic markers.[3,12] Our results (increased MDA 
level and decreased GPx, Cat, GR, GSH, GST and SOD activities in 
the testis tissues of MEP-treated mice) corroborated with recent 
report describing that increased production of free radicals leads to 
apoptotic death by deceased- Bcl-2 gene expression and increased 
Bax gene expression.3 In normal cells, Bax as a pro-apoptotic 
protein has monomeric structure and commonly located in the 
cytosol. The death signals can activate Bax via translocation to the 
mitochondria where it becomes an integral membrane protein and 
cross-linkable as a homodimer.[2,3,16,17] Normally, the presence of 
Bcl-2 as an anti-apoptotic molecule can inhibit the activation of Bax 
following a death signal3, but we noticed that Bax had the capacity 
of killing sperms despite the presence of Bcl-2. The Bcl-2 gene 
expression (as an anti-apoptotic protein) decreased and Bax gene 
expression (as a pro-apoptotic protein) increased in epididymal 
sperm of melphalan treated mice. These results are in alignment 
with the observed oxidative stress-related effects in normal organs 
and especially male reproductive system of patients undergoing 
chemotherapy,[3] as one of the mechanisms by which chemotherapy 
drugs has been reported to function is by induction of apoptosis. 
So, MEP-mediated apoptosis in sperm and testis was as a result 
of increased-ROS generation which resulted in oxidative stress 
and changes in expression of Bax and Bcl-2 Apoptotic Regulatory 
Proteins. In view of the present observations as well as the above-
cited reports, it is relevant to conclude that oxidative stress induced 
by melphalan treatment and expression of Bax and bcl-2 family 
gene following treatment with melphalan play a major role during 
apoptosis in sperm cells and can lead to spermatogenic dysfunction 
of adult mice. These results likewise confirm that ROS can induce 
apoptosis in epididymal sperm by increasing pro-apoptotic protein 
levels and decreasing anti-apoptotic protein expression following 
melphalan treatment.
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